Spire Healthcare Group plc (LON:SPI - Get Free Report) shares rose 9.1% on Friday . The company traded as high as GBX 242.61 ($3.08) and last traded at GBX 239.50 ($3.04). Approximately 1,545,344 shares changed hands during mid-day trading, an increase of 187% from the average daily volume of 537,597 shares. The stock had previously closed at GBX 219.50 ($2.79).
Analyst Upgrades and Downgrades
Separately, Berenberg Bank restated a "buy" rating and issued a GBX 300 ($3.81) price objective on shares of Spire Healthcare Group in a report on Tuesday, September 17th.
View Our Latest Research Report on Spire Healthcare Group
Spire Healthcare Group Trading Up 3.6 %
The firm has a market cap of £918.69 million, a PE ratio of 3,400.00, a PEG ratio of 1.06 and a beta of 0.96. The company has a quick ratio of 0.74, a current ratio of 0.70 and a debt-to-equity ratio of 169.51. The stock's fifty day simple moving average is GBX 223.86 and its two-hundred day simple moving average is GBX 239.38.
Insider Transactions at Spire Healthcare Group
In other news, insider Justin Ash bought 21,100 shares of the company's stock in a transaction dated Tuesday, September 17th. The shares were purchased at an average price of GBX 236 ($3.00) per share, for a total transaction of £49,796 ($63,208.94). Insiders own 34.71% of the company's stock.
About Spire Healthcare Group
(
Get Free Report)
Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.
Further Reading
Before you consider Spire Healthcare Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Spire Healthcare Group wasn't on the list.
While Spire Healthcare Group currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
